Forestar Group (FOR) Drops 5.59% on January 15

Equities Staff |

Forestar Group (FOR) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 5.59% to $8.78, a loss of $-0.52 per share. Starting at an opening price of $9.01 a share, the stock traded between $8.60 and $9.06 over the course of the trading day. Volume was 190,991 shares over 1,296 trades, against an average daily volume of 283,330 shares and a total float of 33.62 million.

The losses send Forestar Group down to a market cap of $295.15 million. In the last year, Forestar Group has traded between $16.35 and $8.82, and its 50-day SMA is currently $11.97 and 200-day SMA is $13.28.

Forestar Group Inc is a real estate and oil and gas company. The Company owns 113,000 acres of real estate including about 102,000 acres with timber. It also has 960,000 net acres of oil and gas mineral interests in the continental U.S.

Forestar Group is based out of Austin, TX and has some 150 employees. Its CEO is Phillip J. Weber.

For a complete fundamental analysis analysis of Forestar Group, check out’s Stock Valuation Analysis report for FOR. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.